← Back to Search

iParent2Parent Support Program for Kidney Transplant Parents

N/A
Recruiting
Led By Samantha J. Anthony, PhD, MSW
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to program completion, an average of one year
Awards & highlights
No Placebo-Only Group

Summary

This trial will connect parents of pediatric kidney transplant recipients to offer peer support and mentorship, improving mental health & long-term patient health.

Who is the study for?
This trial is for parents of children under 18 who had a kidney transplant at least two months ago, or under 21 if they're one year post-transplant. They need to speak English and have access to WhatsApp on a device. To be mentors, they must be recommended by their child's healthcare team.
What is being tested?
The iParent2Parent (iP2P) program is being tested. It's an online mentorship where parents of pediatric kidney transplant recipients give each other support. Participants are randomly chosen to either join iP2P or a control group without this peer support.
What are the potential side effects?
Since the intervention involves social support and not medical treatment, there aren't typical side effects like with drugs or surgery. However, participants may experience emotional impacts from sharing experiences.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to program completion, an average of one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to program completion, an average of one year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability (Mentees)
Acceptability (Mentors)
Adherence with the iParent2Parent program
+5 more
Secondary study objectives
Coping (Mentees and Mentors)
Family Functioning (Mentees and Mentors)
Parenting stress (Mentees and Mentors)
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: iParent2Parent ProgramExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
iParent2Parent Program
2019
N/A
~10

Find a Location

Who is running the clinical trial?

The Hospital for Sick ChildrenLead Sponsor
710 Previous Clinical Trials
6,958,141 Total Patients Enrolled
Samantha J. Anthony, PhD, MSWPrincipal InvestigatorThe Hospital for Sick Children
1 Previous Clinical Trials
55 Total Patients Enrolled

Media Library

iParent2Parent Program Clinical Trial Eligibility Overview. Trial Name: NCT05968833 — N/A
Kidney Transplant Research Study Groups: iParent2Parent Program
Kidney Transplant Clinical Trial 2023: iParent2Parent Program Highlights & Side Effects. Trial Name: NCT05968833 — N/A
iParent2Parent Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05968833 — N/A
~17 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top